HOBART, Okla., June 9, 2005 /PRNewswire via COMTEX/ -- Response Scientific, Inc., announced today the launch of InResponse(R), a patented antioxidant supplement clinically proven to promote healthy blood glucose levels and support insulin function. The supplement, under development since 1996, has been shown in two clinical trials to support blood glucose metabolism and promote healthy HbA1c (Glycated Hemoglobin) levels. The product will be rolled out through pharmacies and select natural products retailers beginning in June.
Testing of the product has included an open-label clinical study on 90 patients conducted at major medical centers, and a 20-patient confirmatory, double-blind, placebo-controlled, randomized clinical study at Duke University Medical Center. The studies showed that InResponse's antioxidant formulation reduced blood glucose levels by as much as 20 percent after three months. The product has no known side effects or contraindications when used in conjunction with other blood glucose lowering agents.
Control of blood glucose levels is a day-to-day concern for the millions of Americans suffering from diabetes. According to the National Institutes of Health, approximately 18 million people have diabetes in the United States. Approximately 1.3 million new cases are diagnosed each year.
InResponse was specifically cited in the January 2004 issue of the Journal of Investigative Medicine in a review article by Emmanuel C. Opara, Ph.D., Research Professor of Biomedical Science at the Pritzker Institute of Biomedical Engineering at Illinois Institute of Technology in Chicago, Illinois.* Dr. Opara, who led one of the studies of InResponse while at Duke University Medical Center, has been published widely on the role of oxidative stress in diabetes, and the emerging concept of using antioxidant supplementation to help manage blood glucose levels and the associated complications of diabetes.
"It has been suggested that some degree of supplementation with certain vitamins and minerals would be worthwhile for the regulation of blood glucose levels in diabetic patients," Dr. Opara commented. "This concept has been supported by the data that I obtained in the open label study with the InResponse formulation."
Oxidative stress is the result of an imbalance of antioxidants within the blood stream, which causes blood glucose levels to rise above healthy levels. InResponse has a unique combination of proven antioxidant ingredients, in specific strengths, reducing the stress from the oxidative process. Reducing oxidative stress is important in the proper metabolism of insulin, and enables the body to utilize insulin more efficiently. Response Scientific, maker of InResponse, utilizes only pharmaceutical-grade ingredients in the forms that are most bio-available.
According to Timothy J. Lyons, M.D., Chief, Section of Endocrinology, William K. Warren Professor of Diabetes Studies at the University of Oklahoma Health Sciences Center (OUHSC), "Oxidative stress and its relationship to blood glucose levels and the many complications resulting from poor control continues to be a hot topic with researchers. It was the subject of the Banting Lecture (named for the discoverer of Insulin) at last year's scientific sessions of the American Diabetes Association. The InResponse product looks of considerable interest, and we look forward to conducting further studies here at OUHSC."
"Today, many people are looking for ways to combine nutrition, exercise and other means to promote healthy blood glucose levels," said Gregg Webster, President and CEO of Response Scientific. "InResponse offers a new tool-a nutritional supplement that is supported by sound science-for consumers who are trying to actively manage their blood sugar levels to promote their overall health."
About Response Scientific
Response Scientific ( http://www.responsescientific.com ) is a privately held company committed to the research and delivery of innovative healthcare products that enable people to live longer, healthier and more active lives.
* "Role of Oxidative Stress in the Etiology of Type 2 Diabetes and the Effect of Antioxidant Supplementation on Glycemic Control," Emmanuel C. Opara, Journal of Investigative Medicine, Vol. 52, Issue 01-S1, January 2004.